Certified Advisory Corp’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,419
| Closed | -$209K | – | 275 |
|
|
2022
Q4 | $209K | Sell |
7,419
-1,294
| -15% | -$36.5K | 0.04% | 222 |
|
|
2022
Q3 | $286K | Buy |
8,713
+38
| +0.4% | +$1.25K | 0.07% | 181 |
|
|
2022
Q2 | $273K | Hold |
8,675
| – | – | 0.06% | 181 |
|
|
2022
Q1 | $398K | Buy |
8,675
+353
| +4% | +$16.2K | 0.08% | 161 |
|
|
2021
Q4 | $510K | Sell |
8,322
-15
| -0.2% | -$919 | 0.11% | 157 |
|
|
2021
Q3 | $623K | Buy |
8,337
+200
| +2% | +$14.9K | 0.15% | 139 |
|
|
2021
Q2 | $753K | Buy |
8,137
+1,342
| +20% | +$124K | 0.19% | 120 |
|
|
2021
Q1 | $603K | Buy |
+6,795
| New | +$603K | 0.16% | 127 |
|
|
2020
Q2 | $218K | Buy |
4,187
+400
| +11% | +$20.8K | 0.07% | 176 |
|
|
2020
Q1 | $118K | Sell |
3,787
-491
| -11% | -$15.3K | 0.05% | 195 |
|
|
2019
Q4 | $143K | Hold |
4,278
| – | – | 0.05% | 206 |
|
|
2019
Q3 | $126K | Sell |
4,278
-515
| -11% | -$15.2K | 0.04% | 213 |
|
|
2019
Q2 | $165K | Buy |
4,793
+1,500
| +46% | +$51.6K | 0.06% | 185 |
|
|
2019
Q1 | $108K | Buy |
3,293
+580
| +21% | +$19K | 0.05% | 208 |
|
|
2018
Q4 | $65K | Buy |
2,713
+500
| +23% | +$12K | 0.03% | 241 |
|
|
2018
Q3 | $74K | Buy |
+2,213
| New | +$74K | 0.03% | 238 |
|